Course overview

COVID-19 and Cardiovascular Impact

In this course, faculty educate you on the implications of viral infections and bacterial infections in general, emphasizing how the COVID-19 virus encompasses all of the impacts of these different types of organisms in one virus.
 Faculty

Douglas Harrington, MD

 Conference Series

AIHM 2020 Annual Conference

 Required Lessons

1

 Time to Complete

45 minutes

 Non-CME Eligible*

0 Credits

What you will learn

  • Course Summary

  • In this course, faculty educate you on the implications of viral infections and bacterial infections in general, emphasizing how the COVID-19 virus encompasses all of the impacts of these different types of organisms in one virus. Faculty specifically address cardiovascular impact of COVID-19, such as acute coronary syndrome, plaque instability, hemorrhagic manifestations, thrombosis, and myocardium damage.
    By the end of this course, learners will be able to:

    • Explain the role of infections with cardiovascular diseases.
    • Identify risk factors that induce endothelial injury and inflammation.
    • Discuss the clinical challenges surrounding cardiac diseases and the role of COVID-19.

Course includes:

  • Video recording
  • Downloadable audio
  • Speaker handout(s)
  • 1 Quiz
  • 1 Evaluation
  • Certificate of Completion
  • CME/CEU Credits

Included in this course

Course Faculty

Douglas Harrington, MD

About Douglas
Dr. Douglas Harrington has over 30 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. As former President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings.

Dr. Harrington holds a number of patents including automated image analysis of residual cancer protein, catalytic heavy metal extraction, and biomarker assays for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies – from devices to molecular genetics focusing on immunology, cancer and cardiology, where he has taken a number of new molecular technologies through state and federal regulatory approval.

*CME/CEU Credits

This course is not eligible for CME/CEU credits.

Enroll Now!

This course is self-paced with no set beginning or end date. You may complete this course on your own schedule and pace. Enrolling in and purchasing this course grants you access to its contents in perpetuity.